Clicky

Nexien Biopharma Inc.(NXEN)

Description: Nexien BioPharma, Inc., a pharmaceutical development company, engages in the formulation, development, and commercialization of cannabinoid-based pharmaceuticals to address a range of medical conditions and disorders. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. The company is based in Glendale, Colorado. Nexien BioPharma, Inc. is a subsidiary of Intiva USA Inc.


Keywords: Biotechnology Life Sciences Disorders Pharmaceutical Development Nexi Public Key Cryptography

Home Page: www.nexienbiopharma.com

4340 East Kentucky Avenue
Glendale, CO 80246
United States
Phone: 303 495 7583


Officers

Name Title
Mr. Richard S. Greenberg Founder, CEO, Exec. VP & Chairman
Mr. Evan L. Wasoff CPA Chief Financial Officer
Mr. Robert I. Goldfarb J.D., Esq. Chief Operating Officer
Dr. Linda Klumpers Ph.D. Consultant
Mr. Joseph Morgan Consultant
Mr. Paul Wilkenson Ph.D. Consultant

Exchange: OTCQB

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 205.4105
Price-to-Sales TTM: 0
IPO Date:
Fiscal Year End: June
Full Time Employees: 0
Back to stocks